https://www.zynlonta.com/
r/r DLBCL Treatment | ZYNLONTA® (loncastuximab tesirine-lpyl) Patient Site
ZYNLONTA® (loncastuximab tesirine) is a therapy for adults with diffuse large B-cell lymphoma after at least 2 therapies. See Important Risk Info. Rx Only.
patient siterdlbcl
https://www.journalhaema.de/lymphome/non-hodgkin-lymphom/dlbcl/ash-2025-daten-erstlinie-rezidiv
ASH 2025: DLBCL-Therapie von Erstlinie bis Rezidiv
Apr 17, 2026 - Daten vom ASH 2025 zu Pola + R-CHP bekräftigen dessen Wirksamkeit und Sicherheit bei Patienten mit nicht vorbehandeltem 1L DLBCL. Hier mehr erfahren!
ashdlbcltherapievonbis
https://registry.opendata.aws/nciccr-dlbcl/
National Cancer Institute Center for Cancer Research - Diffuse Large B Cell Lymphoma (DLBCL)...
national cancer institutecenter for research
https://alpha3trial.com/
ALPHA3 Clinical Trial: Diffuse Large B-Cell Lymphoma (DLBCL)
Sep 15, 2025 - Join the ALPHA3 Clinical Trial for advanced lymphoma treatment. Learn about DLBCL symptoms, diagnosis, and therapy options. See if you qualify today!
clinical trialdiffuselargeb
https://www.everydayhealth.com/cancer/diffuse-large-b-cell-lymphoma/
Diffuse Large B-Cell Lymphoma (DLBCL): Symptoms, Causes, Diagnosis, Treatment, and Prevention
Mar 14, 2025 - Explore diffuse large B-cell lymphoma — symptoms, causes, diagnosis, treatment options, and prevention. Learn about its types, risk factors, and prognosis.
diffuselargeb
https://www.biospace.com/genentech-to-present-positive-data-for-agressive-lymphoma-antibody-at-asco
Genentech Announces Optimistic Data in Aggressive DLBCL - BioSpace
May 27, 2022 - Genentech announced new data related to its investigational CD20xCD3 T-cell engaging bispecific antibody intended to treat relapsed or refractory diffuse large...
genentechannouncesoptimisticdataaggressive
https://www.journalhaema.de/news/medizin/neue-angriffsstelle-zur-behandlung-von-dlbcl-entdeckt
Neue Angriffsstelle zur Behandlung von DLBCL entdeckt
May 2, 2026 - Ein Schlüsselprotein reguliert den Zelltod bei Lymphomen. Die Entdeckung könnte resistenten Patient:innen neue Therapien ermöglichen. Mehr dazu hier!
zur behandlungneuevondlbclentdeckt
https://www.sobi.com/en/diffuse-large-b-cell-lymphoma
Diffuse large B-cell lymphoma (DLBCL) | Sobi
Diffuse large B-cell lymphoma is a fast-growing blood cancer affecting the lymphatic system. Learn about DLBCL symptoms, treatments, diagnosis and outcomes
diffuselargebcelllymphoma
https://www.cancernetwork.com/view/adult-t-cell-leukemia-lymphoma-and-epstein-barr-virus-positive-dlbcl-a-rare-concomitant-association
Adult T-Cell Leukemia/Lymphoma and Epstein-Barr Virus–Positive DLBCL: A Rare Concomitant...
t cellepstein barradultleukemialymphoma